Observational studyCritical care explorations2026
Performance of Thromboelastography 6s Difference in Reaction Time Between Heparinase-Free and Heparinase-Containing Channel for Detecting Subtherapeutic Unfractionated Heparin Anticoagulation in a Pediatric Cardiac ICU.
Observational study in Critical care explorations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesIn cases where anti-Xa activity is not routinely measurable, estimating heparin efficacy using the activated partial thromboplastin time (APTT) is challenging, and misestimation may risk bleeding or thrombotic complications. We aimed to assess the utility of the difference in reaction time between thromboelastography 6s heparinase-free and heparinase-containing channel, termed "ΔR," as a potential diagnostic test for monitoring the heparin effect in a pediatric cardiac ICU (PCICU), using anti-Xa activity as a reference standard, and APTT (seconds and preoperative ratio; APTT at sampling divided by the preoperative value) as comparators.
designSingle-center, prospective observational diagnostic performance study.
settingThe PCICU of a national cardiovascular center in Japan. PATIENTS: Consecutive patients younger than 18 years old who received unfractionated heparin in the PCICU between July 5, 2024, and May 31, 2025.
interventionsNone. MEASUREMENTS AND MAIN
resultsThe ΔR, anti-Xa activity, and APTT (seconds and preoperative ratio) were measured for each patient on concurrent samples. Among 59 patients, the ΔR correlated moderately with anti-Xa (r = 0.67; p < 0.001), whereas correlations between anti-Xa activity and APTT were weak (seconds: r = 0.06; p = 0.65 and ratio: r = 0.24; p = 0.066). For the primary target condition (anti-Xa < 0.1 international units/mL), ΔR achieved an area under the curve of 0.934 (95% CI, 0.841-0.996) with an optimal cutoff of 5.6 min (95% CI, 4.35-6.35), yielding 96% sensitivity and 83% specificity, thus outperforming APTT (seconds and ratio; p < 0.001).
conclusionsΔR showed a moderate correlation with anti-Xa and high discriminative performance in identifying subtherapeutic anticoagulation, thus supporting its use as a surrogate marker for heparin monitoring in PCICUs. However, further external validation and outcome-based studies are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.